Squarepoint Ops LLC Tyme Technologies, Inc. Transaction History

Squarepoint Ops LLC

$59.6 Billion
Q2 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$1.14 - $1.87 $15,668 - $25,701	-13,744 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.34 - $3.53 $18,416 - $48,516	13,744 New	13,744 $24,000
Q3 2020 Nov 16, 2020	SELL	$0.93 - $1.35 $52,526 - $76,248	-56,480 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.97 - $1.7 $54,785 - $96,016	56,480 New	56,480 $75,000
Q1 2020 May 15, 2020	SELL	$0.9 - $1.95 $22,856 - $49,522	-25,396 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.0 - $1.49 $34,022 - $50,692	-34,022 Reduced 57.26%	25,396 $36,000
Q3 2019 Nov 14, 2019	BUY	$0.97 - $1.77 $57,635 - $105,169	59,418 New	59,418 $71,000

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.